Concurrent celecoxib versus placebo in patients with stage II-III non-small cell lung cancer: A randomised phase II trial

被引：12

作者：

De Ruysscher, Dirk

Bussink, Johan

Rodrigus, Patrick

Kessels, Alfons

Dirx, Miranda

Houben, Ruud

Wanders, Rinus

机构：

[1] Univ Hosp Maastricht, Dept Radiat Oncol, GROW, NL-6229 ET Maastricht, Netherlands

[2] MAASTRO Clin, Maastricht, Netherlands

[3] Radboud Univ Nijmegen, Med Ctr, Dept Radiat Oncol, Nijmegen, Netherlands

[4] Bernard Verbeeten Inst, Tilburg, Netherlands

[5] Univ Hosp Maastricht, Dept Hlth Technol Assessment, Maastricht, Netherlands

[6] Comprehens Canc Ctr Limburg, Maastricht, Netherlands

来源：

RADIOTHERAPY AND ONCOLOGY | 2007年 / 84卷 / 01期

关键词：

COX-2; celecoxib; randomised; phase II; NSCLC; radiotherapy;

D O I：

10.1016/j.radonc.2007.05.008

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

In several pre-clinical models, cyclooxygenase (COX) inhibitors increase radio-sensitivity of tumours, whilst not affecting normal tissues. A randomised phase II trial comparing concurrent radiotherapy with either celecoxib or placebo in patients with stage II-III non-small cell lung cancer was therefore initiated. Because of poor recruitment, the study was stopped after the enrollment of 41 patients, instead of the foreseen 102. None of the endpoints differed significantly between both groups. However, due to the limited number of patients, no definitive conclusions can be drawn. (c) 2007 Elsevier Ireland Ltd. All rights reserved.

引用

页码：23 / 25

页数：3

共 50 条

[31] Treatment and toxic effects of prophylactic cranial irradiation in stage II-III non-small cell lung cancer: A meta-analysis [J].

Li, Meng ;

Wang, Taifang ;

Wen, Ping ;

Wang, Xiang ;

Wu, Chunli .

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 (02) :E18-E26

[32] Oral vinorelbine versus etoposide with cisplatin and chemo-radiation as treatment in patients with stage III non-small cell lung cancer: A randomized phase II (RENO study) [J].

Isla, Dolores ;

De Las Penas, Ramon ;

Insa, Amelia ;

Marse, Raquel ;

Martinez-Banaclocha, Natividad ;

Mut, Pilar ;

Moran, Teresa ;

Angeles Sala, Maria ;

Massuti, Bartomeu ;

Laura Ortega, Ana ;

Miguel Jurado, Jose ;

Gomez-Codina, Jose ;

Diz, Pilar ;

Artal, Angel ;

Gutierrez, Vanesa ;

Francisca Vazquez, Maria ;

Vinolas, Nuria ;

Maestu, Inmaculada ;

Camps, Carlos ;

Alvarez, Rosa ;

de Mon Soto, Melchor Alvarez ;

Ponce, Santiago ;

Provencio, Mariano .

LUNG CANCER, 2019, 135 :161-168

[33] PHASE I/II TRIAL OF RECOMBINANT HUMAN ENDOSTATIN IN COMBINATION WITH CONCURRENT CHEMO-RADIOTHERAPY IN THE PATIENTS WITH STAGE III NON-SMALL-CELL LUNG CANCER [J].

Chen, Ming ;

Bao, Yong ;

Peng, Fang ;

Zhou, Qi C. ;

Yu, Zhong Hua ;

Li, Jian Cheng ;

Cheng, Zhi Bin ;

Chen, Long ;

Hu, Xiao ;

Chen, Yuan Y. ;

Wang, Jin ;

Ma, Hong Lian .

JOURNAL OF THORACIC ONCOLOGY, 2013, 8 :S410-S411

[34] IDEAL-CRT: A Phase 1/2 Trial of Isotoxic Dose-Escalated Radiation Therapy and Concurrent Chemotherapy in Patients With Stage II/III Non-Small Cell Lung Cancer [J].

Landau, David B. ;

Hughes, Laura ;

Baker, Angela ;

Bates, Andrew T. ;

Bayne, Michael C. ;

Counsell, Nicholas ;

Garcia-Alonso, Angel ;

Harden, Susan V. ;

Hicks, Jonathan D. ;

Hughes, Simon R. ;

Illsley, Marianne C. ;

Khan, Iftekhar ;

Laurence, Virginia ;

Malik, Zafar ;

Mayles, Helen ;

Mayles, William Philip M. ;

Miles, Elizabeth ;

Mohammed, Nazia ;

Ngai, Yenting ;

Parsons, Emma ;

Spicer, James ;

Wells, Paula ;

Wilkinson, Dean ;

Fenwick, John D. .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 95 (05) :1367-1377

[35] Phase II Study of Pemetrexed and Cisplatin, with Chest Radiotherapy Followed by Docetaxel in Patients with Stage III Non-small Cell Lung Cancer [J].

Gadgeel, Shirish M. ;

Ruckdeschel, John C. ;

Patel, Bhaumik B. ;

Wozniak, Antoinette ;

Konski, Andre ;

Valdivieso, Manuel ;

Hackstock, Deborah ;

Chen, Wei ;

Belzer, Kimberly ;

Burger, Angelika M. ;

Marquette, Lauren ;

Turrisi, Andrew .

JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (05) :927-933

[36] Treatment Variation of Sequential versus Concurrent Chemoradiotherapy in Stage III Non-Small Cell Lung Cancer Patients in the Netherlands and Belgium [J].

Walraven, I. ;

Damhuis, R. A. ;

ten Berge, M. G. ;

Rosskamp, M. ;

van Eycken, L. ;

de Ruysscher, D. ;

Belderbos, J. S. A. .

CLINICAL ONCOLOGY, 2017, 29 (11) :E177-E185

[37] Phase II Study of Celecoxib and Docetaxel in Non-small Cell Lung Cancer (NSCLC) Patients with Progression after Platinum-Based Therapy [J].

Schneider, Bryan J. ;

Kalemkerian, Gregory P. ;

Kraut, Michael J. ;

Wozniak, Antoinette J. ;

Worden, Francis P. ;

Smith, Daryn W. ;

Chen, Wei ;

Gadgeel, Shirish M. .

JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (12) :1454-1459

[38] Olaparib maintenance versus placebo monotherapy in patients with advanced non-small cell lung cancer (PIN): A multicentre, randomised, controlled, phase 2 trial [J].

Fennell, Dean A. ;

Porter, Catharine ;

Lester, Jason ;

Danson, Sarah ;

Blackhall, Fiona ;

Nicolson, Marianne ;

Nixon, Lisette ;

Gardner, Georgina ;

White, Ann ;

Griffiths, Gareth ;

Casbard, Angela .

ECLINICALMEDICINE, 2022, 52

[39] A Phase II Trial of Erlotinib and Concurrent Palliative Thoracic Radiation for Patients With Non-Small-Cell Lung Cancer [J].

Swaminath, Anand ;

Wright, James R. ;

Tsakiridis, Theodoros K. ;

Ung, Yee C. ;

Pond, Gregory R. ;

Sur, Ranjan ;

Corbett, Thomas B. ;

Okawara, Gordon ;

Leyine, Mark N. .

CLINICAL LUNG CANCER, 2016, 17 (02) :142-149

[40] Definitive radiotherapy alone over 60 Gy for patients unfit for combined treatment to stage II-III non-small cell lung cancer: retrospective analysis [J].

Ji Hyeon Joo ;

Si Yeol Song ;

Su Ssan Kim ;

Yuri Jeong ;

Seong-Yun Jeong ;

Wonsik Choi ;

Eun Kyung Choi .

Radiation Oncology, 10

← 1 2 3 4 5 →